Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5330_Библиотеки_им_академика_М_И_Перельмана
.pdf
126
https://t.me/medicina_free
C. S. Kılıç
and their anti-obesity effects in high-fat diet-induced obese mice.
Phytomedicine. 2021;81:153362.
166. De Morais Lima G, da Silva Brito AK, de Farias LM, Rodrigues
LARL, de Carvalho Pereira CF, Lima SKR, de Macedo Gonçalves
Frota K, dos Santos Rizzo M, Nunes PHM, Lucarini M, Durazzo
A, Arcanjo DDR, do Carmo de Carvalho e Martins M. Effects
of “Bacuri” seed butter (Platonia insignis Mart.) on metabolic
parameters in hamsters with diet-induced hypercholesterolemia.
Evid Based Complement Alternat Med. 2021;2021:5584965.
https://doi.org/10.1155/2021/5584965.
167. Sung YY, Yoon T, Yang W-K, Kim SJ, Kim D-S, Kim
HK. The antiobesity effect of Polygonum aviculare L. etha-
nol extract in high- fat diet-induced obese mice. Evid Based
Complement Alternat Med. 2013;2013:626397. https://doi.
org/10.1155/2013/626397.
168. Azizah RN, Emelda A, Asmaliani I, Ahmad I, Fawwaz M.Total
phenolic, avonoid and carotenoids content and anti-obesity
activity of purslane herb (Portulaca oleracea L.) ethanol extract.
Pharm J. 2022;14(1):8–13.
169. Bahadori MB, Zengin G, Bahadori S, Maggi F, Dinparast
L.Chemical composition of essential oil, antioxidant, antidiabetic
anti-obesity and neuroprotective properties of Prangos gaubae.
Nat Prod Commun. 2017;12(12):1945–8.
170. Xia D, Wu X, Yang Q, Gong J, Zhang Y.Anti-obesity and hypolipidemic effects of a functional formula containing Prunus mume
in mice fed high-fat diet. Afr J Biotechnol. 2010;9(16):2463–7.
171. Simao AA, Marques TR, Marcussi S, Correa AD. Aqueous
extract of Psidium guajava leaves: phenolic compounds and
inhibitory potential on digestive enzymes. Ann Braz Acad Sci.
2017;89(3):2155–65.
172. Kamiya T, Sameshima-Kamiya M, Nagamine R, Tsubata M,
Ikegucji M, Takagaki K, Shimada T, Aburada M. The crude
extract from Puerariae ower exerts antiobesity and antifatty
liver effects in high-fat diet-induced obese mice. Evid Based
Complement Alternat Med. 2012;2012:272710. https://doi.
org/10.1155/2012/272710.
173. Olonsan KA, Salau VF, Erukainure OL, Islam MS. Senna
petersiana (Bolle) leaf extract modulates glycemic hemostasis and improves dysregulated enzyme activities in fructosefed streptozotocin-induced diabetic rats. J Ethnopharmacol.
2023;303:115998.
174. Nikam SA, Kolhe SU, Tembhurne SV.Preclinical evaluation of
Sesbania grandiora ower extract for antihyperlipidemic and
antiobesity activity on experimental rats. J Drug Deliv Ther.
2019;9(3):537–43.
175. Rani KN, Swapna M, Pavani K, Jyothsna, Divya K, Rao V.Effect
of anti-obesity activity of Setaria italica on rats by using food
induced obesity method. Pharma Innov. 2020;9(7):280–4.
176. Honore SM, Grande MV, Rojas JG, Sanchez SS. Smallanthus son-
chifolius (Yacon) our improves visceral adiposity and metabolic
parameters in high-fat-diet-fed rats. J Obes. 2018;2018:5341384.
https://doi.org/10.1155/2018/5341384.
177. Balamurgan R. Smilax chinensis Linn. (Liliaceae) root attenuates insulin resistance and ameliorate obesity in high diet induced
obese rat. South Indian J Biol Sci. 2015;1(1):47–51.
178. Aabideen ZU, Mumtaz MW, Akhtar MT, Raza MA, Mukhtar H,
Irfan A, Raza SA, Nadeem M, Ling YS.Anti-obesity effect and
UHPLC-QTOF-MS/MS based metabolite proling of Solanum
nigrum leaf extract. Asian Pac J Trop Biomed. 2022;12(4):164–74.
179. El-shiekh RA, Al-Mahdy DA, Mouneir SM, Hifnawy MS, AbdelSattar EA.Anti-obesity effect of argel (Solenostemma argel) on
obese rats fed a high fat diet. J Ethnopharmacol. 2019;238:111893.
180. Thuoc DV, Mai NTM, Ha LTV, Hung LD, Tra DH, Hung NK,
Hung NP.Evaluation of antibacterial, antioxidant and antiobese
activities of the fruit juice of crabapple mangrove Sonneratia
caseolaris (Linn.). Int J Agric Sci Nat Res. 2018;5(2):25–9.
181. Ejere VC, Ogbuke EF, Nnamonu EI, Ikele BC, Nweze
BC.Evaluation of anti-obesity potentials of Sphenostylis steno-
carpa ethanolic seed extract. Annu Res Rev Biol. 2018;26(3):1–9.
182. Kaveripakam SS, Adikay S, Retnasamy G.Anti-obesity efcacy
of roots of Stereospermum suaveolens in high fat-induced obese
rats. J Young Pharm. 2017;9(2):234–8.
183. Shaheen SM, Azad AKM, Ferdous W, Jashim MU. Antiobesity
report of a sweet super leaves, Stevia rebaudiana (Bert.) in mice
model. Pharmacol Online. 2019;2:1–8.
184. Jung CH, Ahn J, Jeon T-I, Kim TW, Ha TY. Syzygium aromati-
cum ethanol extract reduces high-fat diet-induced obesity in mice
through downregulation of adipogenic and lipogenic gene expression. Exp Ther Med. 2012;4:409–14.
185. Iwamoto K, Fukuda Y, Tokikura C, Noda M, Yamamoto A,
Yamamoto M, Yamashita M, Zaima N, Iida A, Moriyama T.The
anti-obesity effect of Taheebo (Tabebuia avellanedae Lorentz ex
Griseb) extract in ovariectomized mice and the identication of a
potential anti-obesity compound. Biochem Biophys Res Commun.
2016;478:1136–40.
186. Azman KF, Amom Z, Azlan A, Esa NM, Ali RM, Shah ZM,
Abdul Kadir KK.Antiobesity effect of Tamarindus indica L. pulp
aqueous extract in high-fat diet-induced obese rats. J Nat Med.
2012;66:333–42.
187. Asgary S, Soltani R, Barzegar N, Sarrafzadegan N.Evaluation on
the effects of Tamarindus indica L. fruit on body weight and sev-
eral cardiometabolic risk factors in obese and overweight adult
patients: a randomized controlled clinical trial. Int J Prev Med.
2020;11:24.
188. Valaparla GR, Sai GV, Kumar D. Assessment of anti-obesity
activity of Tamarindus leaves on butter induced hyperlipidemia in
mice. Asian J Pharm Pharmacol. 2022;8(3):100–3.
189. Wiyono T, Frediansyah A, Sholikhah EN, Pratiwi WR.UHPLCESI- MS analysis of Javanese Tamarindus indica leaves from various tropical zones and their benecial properties in relation to
antiobesity. J Appl Pharm Sci. 2022;12(8):137–47.
190. Wang Y, Deng M, Zhang S-Y, Zhou Z-K, Tian W-X. Parasitic
loranthus from Loranthaceae rather than Viscaceae potently
inhibits fatty acid synthase and reduces body weight in mice. J
Ethnopharmacol. 2008;118:473–8.
191. Dongmo OLM, Ashu ELA, Tadjoua HT, Epoh NJ, Njina SN,
Tapondjou LA, Telefo PB.Evaluation of anti-obesity and diuretic
effects of aqueous extract of Tetrapleura tetraptera Taub. Stem
bark on high fat diet-induced obese rats. Eur J Pharm Med Res.
2019;6(1):27–37.
192. Retnasamy G, Adikey S.Evaluation of anti-obesity activity of
Thespesia populnea (L.) and avonoid isolated quercetin on high
fat diet-induced obese rats. J Exp Appl Anim Sci. 2016;2(1):46–58.
193. Putro PS, Indarto D, Purwanto B, Koeswondo W, Kusumaningrum
S, Nguzum KY.The effects of leaves extract of Toddalia aculeata
on body weight, body mass index, body fat content and resistive
index in male rats with high-fat diet. Pharm J. 2022;14(6):771–7.
194. Simao AA, Ramos VO, Correa AD, Sousa RV, Marcussi S.Antiobesity effects of the administration of Tournefortia paniculata
Cham extract on Wistar rats subjected to a hypercaloric diet. Braz
Arch Biol Technol. 2015;58(4):494–503.
195. Goel K, Gupta S, Singh R, Saini V, Chhabra P, Bansal S.Estimation
of anti-obesity potential of Tribulus terrestris in Wistar rats (high
fat diet inducted obesity). HIV Nurs. 2023;23(2):1014–22.
196. Rani VI, Kiranmai G.Anti-obesity activity of methanolic extract of
Tricholepis glaberrima. Indo Am J Pharm Sci. 2017;4(9):2728–34.
197. Lee YY, Kim M, Irfan M, Yuk HJ, Kim D-S, Lee SE, Kim S-H,
Kim S, Kim S-D, Rhee MH. Ulmus parvifolia Jacq. Exhibits
antiobesity properties and potentially induces browning of
white adipose tissue. Evid Based Complement Alternat Med.
2020;2020:9358563. https://doi.org/10.1155/2020/9358563.
Herbal Medicines fortheManagement ofObesity
https://t.me/medicina_free
127
198. Wu T, Jiang Z, Yin J, Long H, Zheng X.Anti-obesity effects of
articial planting blueberry (Vaccinium ashei) anthocyanin in
high-fat diet-treated mice. Int J Food Sci Nutr. 2016;67(3):257–64.
199. Zagayko AL, Kolisnyk TY, Churnak OI, Ruban OA, Koshovyi
OM.Evaluation of anti-obesity and lipid lowering properties of
Vaccinium myrtillus leaves powder extract in a hamster model. J
Basic Clin Physiol Pharmacol. 2018;29(6):697–703.
200. Wang Z, Hwang SH, Kim JH, Lim SS. Anti-obesity effect of
the above-ground part of Valeriana dagetiana Nakai ex F.Maek
extract in high-fat diet-induced obese C57BL/6N mice. Nutrients.
2017;9:689.
201. Smitha AS, Himanshu J, Gururaja MP, Prasanna SK, Ullas
DP.Anti-obesity activity of Vateria indica Linn. Stem barks in
rats. Res J Pharm Technol. 2018;11(12):5238–42.
202. Egedigwe CA, Ijeh II, Okafor PN, Ejike CECC. Aqueous and
methanol extracts of Vernonia amygdalina leaves exert their anti-
obesity effects through the modulation of appetite-regulatory hormones. Pharm Biol. 2016;54(12):3232–6.
203. Yamasaki M, Ogawa T, Wang L, Katsube T, Yamasaki Y, Sun X,
Shiwaku K.Anti-obesity effects of hot water extract from wasabi
(Wasabia japonica) leaves in mice fed high-fat diets. Nutr Res
Pract. 2013;7(44):267–72.
204. Nazish I, Ansari SH, Arora P, Ahmad A.Antiobesity activity of
Zingiber ofcinale. Pharm J. 2016;8(5):440–6.
205. Kim S, Lee M-S, Jung S, Son H-Y, Park S, Kang B, Kim S-Y,
Kim I-H, Kim C-T, Kim Y. Ginger extract ameliorates obesity
and inammation via regulating microRNA-21/132 expression and AMPK activation in white adipose tissue. Nutrients.
2018;10:1567.
206. Kim K, Chung MH, Park S, Cha J, Baek JH, Lee S-Y, Choi
S-Y. ER Stress attenuation by Aloe-derived polysaccharides in
the protection of pancreatic β-cells from free fatty acid-induced
lipotoxicity. Biochem Biophys Res Commun. 2018;500:797–803.
207. Patil SB, Kothavale SD.Antiobesity activity of Zingiber ofci-
nale. Res J Pharmacogn Phytochem. 2022;14(4):252–6.
208. Deshpande MS, Shengule S, Apte KG, Wani M, Piprode V, Parab
PB.Anti-obesity activity of Ziziphus mauritiana: a potent pancreatic lipase inhibitor. Asian J Pharm Clin Res. 2013;6(2):168–73.
209. Çiçek SS. Momordica charantia L.– diabetes-related bioactivities, quality control, and safety considerations. Front Pharmacol.
2022;13:904643.
210. İnce İ, Çığırgil N, Gümüştaş B, Kozguş Güldü Ö, Karaman
D, Medine Eİ, Güler G, Karasulu E. Momordica charantia L.
meyveleri kullanılarak krem hazırlanması, kalite kontrolü ve in
vitro yara iyi edici etkisinin araştırılması. Erzincan Univ J Sci
Technol. 2019;12(1):38–48.
211. Krishnaraju AV, Sundararaju D, Srinivas P, Rao CV, Sengupta K,
Trimurtulu G.Safety and toxicological evaluation of a novel antiobesity formulation LI85008F in animals. Toxicol Mech Methods.
2010;20(2):59–68.
212. Said O, Saad B, Fulder S, Khalil K, Kassis E.Weight loss in animals and humans treated with “weighlevel”, a combination of
four medicinal plants used in traditional Arabic and Islamic medicine. Evid Based Complement Alternat Med. 2011;2011:874538.
https://doi.org/10.1093/ecam/nen067.
213. Avanapu SR, Reddy DS.Anti-obesity effect of a polyherbal formulation in cafeteria and atherogenic diet induced obesity in rats.
Indo Am J Pharm Res. 2013;3(8):6084–93.
214. Brenesel MD, Pilija V, Popovic T, Arsic A, Milic M, Kojic D,
Milic N, Misan A.Antihyperlipidemic, antioxidant and weightlowering effects of “Vitalplant”. Open Life Sci. 2015;10:291–8.
215. Akinseye OR.The hypolipidemic activities of the tea extracts of
St. John’s wort tea, chamomile tea and their blend at different concentrations, orally induced on adult male Wistar rats. J Nat Sci
Res. 2016;6(11):142–6.
216. Yimam M, Jiao P, Hong M, Brownell L, Lee Y-C, Hyun E-J, Kim
H-J, Kim T-W, Nam J-B, Kim M-R, Jia Q. Appetite suppression and antiobesity effect of a botanical composition composed
of Morus alba, Yerba mate, and Magnolia ofcinalis. J Obes.
2016;2016:4670818. https://doi.org/10.1155/2016/4670818.
217. Kim G-N, Shin M-R, Shin SH, Lee AR, Lee JY, Seo B-I, Kim MY,
Kim TH, Noh JS, Rhee MH, Roh S-S.Study of antiobesity effect
through inhibition of pancreatic lipase activity of Diospyros kaki
fruit and Citrus unshiu peel. Biomed Res Int. 2016;2016:1723042.
https://doi.org/10.1155/2016/1723042.
218. Kim D-S, Kim S-H, Cha J.Antiobesity effects of the combined
plant extracts varying the combination ratio of Phyllostachys
pubescens leaf extract and Scutellaria baicalensis root extract.
Evid Based Complement Alternat Med. 2016;2016:9735276.
https://doi.org/10.1155/2016/9735276.
219. Nimmi OS, George P. Antiobesity and antioxidant effects of a
new polyherbal formulation (PHF) in obesity induced Wistar rats.
Indian J Tradit Knowl. 2017;16(2):297–302.
220. Talreja T, Kumar M, Sirohi P, Sharma T.Preparation and use of
Cissus quadrangularis and Achyranthes aspera formulation in the
management of weight loss. Pharma Innov. 2017;6(3):143–51.
221. Kumar P, Singh S, Ahmad MI.Synergistic effect of Cinnamomum
zeylanicum and Murraya koenigii formulation for antiobesity
and hypolipidemic activity on wistar albino rats. Adv Trad Med.
2021;21:553–63.
222. Badshah H, Ullah I, Kim SE, Lee HY, Kim MO. Anthocyanins
attenuate body weight gain via modulating neuropeptide Y
and GABAB1 receptors in rats hypothalamus. Neuropeptides.
2013;47:347–53.
223. Ishaq M, Tran M, Wu Y, Nowak K, Deans B, Xin JTZ, Loh HL, Ng
WY, Yee CW, Southam B, Vicenzi S, Randall C, Yang C, Tan E,
Pasupuleti M, Grewal AK, Ahmad T, Shastri M, Vicario C, Ronci
M, Zuccarini M, Bleasel M, Scowen P, Raffaeli W, D’Andrea G,
Chellappan DK, Jacobson G, Bissember AC, Smith JA, Eri R,
Canales J, Iglesias M, Guben N, Caruso V.Asperuloside enhances
taste perception and prevents weight gain in high-fat fed mice.
Front Endocrinol. 2021;12:615446.
224. Park H-J, Jung EY, Shim I. Berberine for appetite suppressant
and prevention of obesity. Biomed Res Int. 2020;2020:3891806.
https://doi.org/10.1155/2020/3891806.
225. Kumar D, Karmase A, Hagtap S, Shekbar R, Bhutani
KK.Pancreatic lipase inhibitory activity of cassiamin A, a bianthraquinone from Cassia siamea. Nat Prod Commun. 2013;8:1–4.
226. Han L-K, Zheng Y-N, Yoshikawa M, Okuda H, Kimura Y.Antiobesity effects of chikusetsusaponins isolated from Panax japoni-
cus rhizomes. BMC Complement Altern Med. 2005;5:9.
227. Jafari F, Emami SA, Javadi B, Salmasi Z, Tajarani-Najjaran M,
Tajarani-Najjaran Z.Inhibitory effect of saffron, crocin, crocetin,
and safranal against adipocyte differentiation in human adiposederived stem cells. J Ethnopharmacol. 2022;294:115349.
228. Poudel B, Lim S-W, Ki H-H, Nepali S, Lee Y-M, Kim D-K.Dioscin
inhibits adipogenesis through the AMPK/MAPK pathway in 3T3L1 cells and modulates fat accumulation in obese mice. Int J Mol
Med. 2014;34:1401–8.
229. Park S-J, Park JH, Davaatseren M, Kim HJ, Kim M-S, Hur HJ,
Sung M-J, Hwang J-T, Yang HJ, Kwon DY. Euphorbiasteroid,
a component of Euphorbia lathyris L., inhibits adipogenesis of
3T3-L1 cells via activation of AMP-activated protein kinase. Cell
Biochem Funct. 2015;33:220–5.
230. Hsu C-L, Yen G-C.Effect of gallic acid on high fat diet-induced
dyslipidemia, hepatosteatosis and oxidative stress in rats. Br J
Nutr. 2007;98:727–35.
231. Tu PTB, Tawata S. Anti-obesity effects of hispidin and
Alpinia zerumbet bioactives in 3T3-L1 adipocytes. Molecules.
2014;19(10):16656–71.
128
https://t.me/medicina_free
C. S. Kılıç
232. Wang L, Zhang M, Zhang Q, Li L, Wang J, Zhu L, Wei D, Wei P,
Wu C.Antiobesity, regulation of lipid metabolism, and attenuation
of liver oxidative stress effects of hydroxyl-α-sanshool isolated
from Zanthoxylum bungeanum on high-fat diet-induced hyper-
lipidemic rats. Oxidative Med Cell Longev. 2019;2019:5852494.
https://doi.org/10.1155/2019/5852494.
233. Wang Q, Wang S-t, Yang X, You P, Zhang W.Myricetin suppress
differentiation of 3 T3-L1 preadipocytes and enhances lipolysis in
adipocytes. Nutr Res. 2015;35:317–27.
234. Su H-M, Feng L-N, Zheng X-D, Chen W. Myricetin protects
against diet-induced obesity and ameliorates oxidative stress in
C57BL/6 mice. J Zhejiang Univ Sci B. 2016;17(6):437–46.
235. Kamoun J, Rahier R, Sellami M, Koubaaa I, Mansuelle P, Lebrun
R, Berlioz-Barbier A, Fioere M, Alvarez K, Abousaiham A,
Carriere F, Aloulou A.Identication of a new natural gastric lipase
inhibitor from star anise. Food Funct. 2019;10:469–78.
236. Lahrita L, Moriai K, Iwata R, Itoh K, Kato E. Quassinoids in
brucea javanica are potent stimulators of lipolysis in adipocytes.
Fitoterapia, 137: 104250 and licochalcone A through induction of adipocyte browning. Biochem Biophys Res Commun.
2019;503:2117–23.
237. Zheng L, Zhong F, Chen Z, Li G, Zhu Q. Polygonatum sibiricum
polysaccharides protect against obesity and non-alcoholic fatty
liver disease in rats fed a high-fat diet. Food Sci Human Wellness.
2022;11:1043–52.
238. Hwang JT, Kim S, Choi I, Choi SY. Resveratrol analog
4-[2-(3,5-dimethoxyphenyl)vinyl]pyridine reduces differentiation
of the 3T3-L1 adipocyte. Pharm Biol. 2013;51(1):96–9.
239. Lin Y, Ren N, Li S, Chen M, Pu P.Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions. Biomed
Pharmacother. 2019;117:109042.
240. Gwon SY, Choi WH, Lee DH, Ahn JY, Jung CH, Moon BK, Ha
TY. Shikonin protects against obesity through the modulation of
adipogenesis, lipogenesis, and β-oxidation in vivo. J Funct Foods.
2015;16:484–93.
241. Han L-K, Kimura Y, Kawashima M, Takaku T, Taniyama T,
Hayashi T, Zheng Y-N, Okuda H.Anti-obesity effects in rodents of
dietary teasaponin, a lipase inhibitor. Int J Obes. 2001;25:1459–64.
242. Chidrawar VR, Patel KN, Sjeth NR, Shiiromwar SS, Trivedi
P.Antiobesity effect of Stellaria media against drug induced obesity in Swiss albino mice. AYU. 2015;32(4):576–84.
243. Garg A, Singh R. Antiobesity activity of ethanolic extract of
Cassia auriculata in high fat diet induced obese rats. Int J Pharm
Pharm Sci. 2015;7(4):237–43.
244. Lobstein T, Brinsden H, Neveux M.World obesity atlas 2022.
London: World Obesity Federation; 2022.
245. WFO.World Flora online. Published on the Internet. 2023. http://
www.worldoraonline.org. Accessed September 2022-April
2023.
Herbal Medicines fortheManagement
https://t.me/medicina_free
ofDiseases intheHeart, Circulation,
andBlood
JagdishS.Bankar, KajalN.Bondre, PratikshaP.Wagh,
SurbhiS.Bhope, JayeshS.Pande, PrakashR.Itankar,
SatyendraK.Prasad, andShailendraS.Gurav
Abstract
Cardiovascular diseases (CVDs) are the foremost reason
for early death and associated disease complications; their
prevalence is rising worldwide. As a result, CVDs are a
measure of economic and health burden on the country. As
per European statistics, the death rate is 45% of the population. Many allopathic drugs used to treat CVDs have side
effects or adverse effects, and they are responsible for
approximately 8% of hospital admissions in the
USA. Thus, numerous therapeutic plants have typically
been investigated for their potential impact on CVDs. It is
commonly observed that herbal extracts are reached with
many secondary plant metabolites and provide signicant
advantages for treating cardiovascular complications due
to their safety proles. The present chapter was undertaken to give an insight into the cardioprotective potential
of various medicinal plants such as Embilica ofcinalis,
Rauwola serpentina, Terminalia arjuna, Ziziphus oxyphylla, and so on. Many phytomolecules like taxifolin,
caffeic acid, quercetin, rosmarinic acid, arjunolic acid,
andrographolide, and others have therapeutic potential
against CVDs. This chapter provides information about
cardiovascular diseases and gives importance to medicinal
plants in their management and specic mode of action.
Abbreviations
AT1R Angiotensin II type 1 receptor
BDNF Brain-derived neurotrophic factor
CAT Catalase
cGMP Cyclic guanosine monophosphate
ESI-MS/MS Electrospray ionization mass spectrometry
GSH Reduced glutathione
H9c2 Cardiomyoblast
HPLC High performances liquid chromatography
I/R Ischemic–reperfusion
IL-6 Interleukin 1
Keap1 Kelch-like ECH-associated protein 1
LDL Low-density lipoprotein
NF-κB Nuclear factor kappa B
Nrf2 Nuclear factor erythroid 2–related factor 2
ox-LDL Oxidized low-density lipoprotein
SHR Spontaneously hypertensive rats
SOD Superoxide dismutase
TNF alpha Tumour necrosis factor alpha
1 Background
Keywords
Cardiovascular diseases · Embilica ofcinalis ·
Hypertension · Medicinal plants · Phytomolecules ·
Taxifolin
J. S. Bankar · K. N. Bondre · P. P. Wagh · S. S. Bhope · J. S. Pande
· P. R. Itankar · S. K. Prasad (*)
Department of Pharmaceutical Sciences, Rashtrasant Tukadoji
Maharaj Nagpur University, Nagpur, Maharashtra, India
S. S. Gurav (*)
Department of Pharmacognosy, Goa College of Pharmacy, Goa
University, Panaji, Goa, India
e-mail: shailendra.gurav@nic.in
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
A. K. Dhara, S. C. Mandal (eds.), Role of Herbal Medicines, https://doi.org/10.1007/978-981-99-7703-1_7
The annual enumeration of cardiovascular diseases (CVDs)
is approximately 17 million, around 31% of mortality worldwide. As a result, CVDs are a measure of economic and
health burden. The present statistics of the American Heart
Association revealed that, nearly 50% of the population
nearby agonized from CVDs. As per European statistics, the
death rate is 45% of the population. In India, heart disease
begins 10–15 years earlier than in the West. Heart illness
accounts for one-fth of fatalities. The Government of India
decided to reduce hypertension prevalence (high blood pressure) by 25% relative to 2025. Almost 220 million people in
India suffer from hypertension. Thus, the Indian Government
established the Indian Hypertension Control Initiative (IHCI)
to expedite access to treatment options [1]. Heart attacks and
129
130
https://t.me/medicina_free
J. S. Bankar et al.
strokes are typically due to several risk factors, including
cigarette use, an unhealthy diet and obesity, indolence and
alcohol abuse, hypertension, diabetes, and hyperlipidemia
[2]. Synthetic drugs used to treat CVDs have side effects or
adverse effects, and they are responsible for approximately
8% of hospital admissions in the USA.Associated toxicity
issues with these drugs cause 100,000 deaths of people per
year.
Consequently, the trend has increased; people move
towards phytomedicine yearly because they believe it has
minimal side effects [3]. Numerous therapeutic plants
have typically been investigated for their potential impact
on CVDs. Medicinal plants provide signicant advantages
for treating cardiovascular complications due to their
safety proles. In Asian medicine, it has been used for at
least 3000 years [4]. This chapter overviews medicinal
plant-based remedies, particularly for preventing and treating CVDs. Also, evidence on the anti-CVD effects and ethnopharmacological therapeutic potentials of several plants,
including Embilica ofcinalis, Rauwola serpentina,
Terminalia arjuna, Ziziphus oxyphylla, and other plants,
are picked and reviewed. It has been investigated how
these plants are used mainly concerning CVDs like myocardial infarction, hypertension, peripheral vascular dis-
eases, coronary heart disease, cardiomyopathies, and
dyslipidaemias [5].
2 Cardiovascular Diseases andTheir
Pathophysiology
2.1 Hypertension
It is a condition of health in which blood pressure is consistently exerted on the wall of the arteries and is characterized by systolic and diastolic blood pressure (BP) of more
than 140 and 90 mmHg, respectively [6]. As per its type,
primary hypertension has an unknown cause of BP elevation, but secondary hypertension is reported with some
exact reasons like congenital narrowing of the aorta, cirrhosis of the liver, renal diseases, endocrine disorders, alcohol intake, obesity, medication (contraceptive pills,
NSAIDs, cocaine, etc.), neurological disorders (head injury
and brain tumours), and thyrotoxicosis. Normal physiological parameters such as cardiac output, degree of sodium,
water retention in the kidney, and contraction of arteries
and arterioles are signicant determinants of total peripheral resistance [7] (Fig.1).
Fig. 1 Pathophysiology of hypertension
Herbal Medicines fortheManagement ofDiseases intheHeart, Circulation, andBlood
https://t.me/medicina_free
131
2.2 Ischaemic Heart Disease
Ischaemic heart disease (IHD) is a type of cardiac disability
coming from the imbalance between the myocardial fullment and the requirement of O2 carrying blood in the body.
The narrowing or blockage of the coronary arteries is the
initial cause of myocardial anoxia. IHD caused due to some
events such as coronary artery disease (CAD) and vasospasm, which resist the blood ow in the myocardium. It is
also termed ‘atherosclerosis’. Later, it produces inammation, which initiates proteolytic enzyme, making atherosclerotic cap rupture and tissue infarct. These all combined
trigger/affect coronary microcirculation in the coronary
artery [6].
2.3 Atherosclerosis
Low-density lipoprotein (LDL) accumulates in arteries leading to atherosclerosis, a lipid-driven disease that affects
peripheral arteries (arterial elasticity) and causes coronary
heart disease and strokes. Lipids start building up in the subendothelial area (intima) during the early stages of atherosclerosis because of the interplay between apolipoprotein,
which is positive in charge, proteoglycan side chain with a
negative charge, and extracellular matrix molecule made by
smooth muscle cells (SMC) [8]. The macrophages, often
known as ‘foam cells’, are lipid-lled arterial macrophages
that eventually die and collect in the endothelium lining
(intima). Along with other substances, the lining also contains smooth muscle cells, calcium and other mineral salts,
and debris from different types of cells. Consequently, atheromas or atherosclerotic plaques are formed from the small
initial lesions that become larger and thicker. These plaques
make the vessel channel smaller and obstruct blood ow. In
the aorta and major aortic branches, atherosclerotic lesions
are frequently observed. The disorder is also known as coronary heart disease, coronary artery disease, or ischemic heart
disease. When one or more coronary arteries are blocked, a
section of the heart muscle will undergo apoptosis, known as
a myocardial infarction or heart attack. Blood clots and
stroke formation could be mediated by atherosclerotic
lesions of the cerebral arteries [9] (Fig.2).
angina because workload or demand and ischemia are predictable. Compared to unstable angina it is a magnied one
with increasing frequency or intensity of episodes. The frequency and severity of plaque-related arterial constriction
are not entirely consistent; it changes with a typical person’s
variances in arterial tone. The arterial tone is high in the
morning; many people suffer from angina at the start of the
day. During angina, the left ventricular (LV) diastolic pressure usually goes up; sometimes, pulmonary obstruction and
breathing problems can also cause it. Although the precise
process of ischemia induces discomfort is unknown, hypoxia
metabolic products may stimulate the nerve cells [11].
2.5 Arrhythmia
A cardiac arrhythmia is a physiologically unjustied variation in the average heart and/or cardiac rhythm rate. Rhythm
disturbances are mainly due to abnormality in generating
impulses, signal conduction, or both. Bradyarrhythmias are
caused by impaired intrinsic pacemaker function or conduction blockages, primarily in the node that produces impulse
(AV node) or the His–Purkinje system. Abnormal mechanisms of automaticity and re-entry are reasons for most
tachyarrhythmias [12].
2.6 Myocardial Infarction
Myocardial infarction (MI) frequently occurs when coronary
atherosclerosis is built with a luminal thrombus [13]. It gives
several combinations of inammation and endothelial
defects. In about 10% of cases, myocardial infarction may
occur without detecting coronary artery obstruction. The
prognosis and management in such cases differ from coronary artery occlusion [14]. In rare cases, MI is shown without any coronary artery blockage. Compared to coronary
artery occlusion, the management and prospects in such conditions differ. MI is due to several factors like increasing
cholesterol level (LDL), inammation, excessive intake of
alcohol, smoking during the hypertensive condition, and the
presence of diseases like diabetes mellitus and family history
as well [15].
2.4 Angina Pectoris
Angina pectoris is a cardiac-origin disease that results in
chest pain. It is a common observation in medical practices;
IHD predominates among 3–4% in the United Kingdom
adults. According to the report, a total coronary angiogram
was performed each year, and the result was 10% of new
cases of angina found [10]. It may be categorized as stable
2.7 Anaemia
In Greek, ‘an’ refers to lack/deciency, and ‘emia’ means
blood. Anaemia implies a lack of blood (RBCs count). The
formation of red blood cells is mainly regulated by a glycoprotein hormone named erythropoietin (EPO), which is
released by the peritubular cells of the kidney. The hypoxic
condition of the tissue and level of haemoglobin is smoothly
132
https://t.me/medicina_free
J. S. Bankar et al.
Fig. 2 Pathophysiology of atherosclerosis
associated with erythropoietin production. As the haemoglobin level falls below 7.0 g/dL, patients start experiencing
several anaemia-related symptoms, while EPO levels in
anaemic patients with renal failure are lower than expected/
normal [16]. Some dietary and metabolite deciencies like
iron and vitamin B12 can lead to anaemia. Dietary iron deciency, impaired iron absorption, and high requirement (in
children as a growth requirement and in women to full the
minimal range that is affected due to pregnancy or periods)
are general risk factors. Gastrointestinal bleeding and menstruation in women are the most frequent causes of iron deciency anaemia. Iron deciencies in various chronic
inammatory diseases include inammatory bowel disease,
chronic kidney disease, and congestive cardiac failure [17].
Cobalamin (Cbl) (vitamin B12) participates in two enzymatic activities in mammalian cells. Homocysteine (HCys)
is converted into methionine, which is responsible for DNA
formation in the methionine synthase process. DNA and
RNA synthesis decreases, and cells grow more extensively
than typical during early lysis due to vitamin B12/folic acid
deciency [18].
3 Therapeutic Signicance ofMedicinal
Plants andtheir Role inCVD
Traditional medicine and ethnomedicine, the study of conventional drugs used by different ethnic groups, are prevalent
today. In the past, natural resources were the primary supply of
medication for traditional medicine [5]. People use modern
medications more frequently than conventional medications
because they have a faster effect. However, it is costly and has
serious side effects. The anti-arrhythmic drug Amiodarone has
the potential to have an impact on almost every organ system,
including the lungs (pulmonary brosis, acute respiratory distress syndrome), thyroid gland (hypo- and hyperthyroidism),
liver, gastrointestinal tract, eyes, skin, and nervous system
(tremors) [19] and statins, which belong to the anti-hyperlipidemic medication class, also produce the most typical side
effects, including headache, myalgia, dizziness, cardiomyopathy, and an increase in blood transaminase. These toxins frequently damage the kidneys and are hazardous [20]. As a
result, individuals are more likely to use medicinal plants [21].
Due to a greater understanding of how herbs enhance health
Herbal Medicines fortheManagement ofDiseases intheHeart, Circulation, andBlood
https://t.me/medicina_free
133
and quality of life, herbal medicine has acquired universal
medical acceptance. According to growing evidence, using
phytochemicals and complete nutrition derived from plants is
a novel and potential CVD prevention method [22].
The traditional (herbal/alternative) systems of medicine
mention more than 2000 plants, some of which give relief to
people with cardiovascular disorders, particularly hyperlipidemia and ischemic heart disease. There can be no disputing
the undeniable aspect that the usage of herbal medicines for
preventive and therapeutic purposes is expanding globally
due to the widespread assumption that natural goods are riskfree and have few adverse effects. A recent WHO research
revealed that 80% of people in developing countries still rely
on natural remedies from conventional medicine for health
[23]. The prevention of low-density lipoprotein oxidation,
which encourages vasodilatation, is a standard avonoid
action. Plant sterols reduce blood cholesterol uptake, thereby
preventing CVD. By stimulating nuclear factor-erythroid
factor 2-related factor 2 (Nrf2) and avoiding the production
of cholesterol, plant sulphur compounds also prevent CVD
[22]. The details of different medicinal plants playing critical
roles in the treatment of CVD are represented below:
3.1 Acorus (Acorus calamus Linn.,
Acoraceae)
Shah etal. [24] investigated the activity of the Acorus calamus in ischemic cardiac conditions. Rhizomes of the Acorus
calamus were used to perform the study, and as a model, male
rabbits (1–1.5 kg) and bovine hearts were used. Isolated
bovine coronary arterial rings were used to investigate the
coronary vasodilator effect, and rabbit heart was used to study
the effect on heart parameters. They looked at the effect of
Acorus calamus extract at 0.01–10 mg/mL, ethyl acetate fraction and n-hexane fraction on coronary ow, pulse rate, and
force of contraction. These ndings suggested that the Acorus
calamus has a coronary vasodilator action, which may be
mediated by an endothelial-derived hyperpolarizing factor
(EDHF). The partial cardiac suppression effect may be advantageous as total suppression can cause cardiac arrest.
Another study by Shah etal. [25] discovered that crude
extract and ethyl acetate fraction inhibited the formation of
phenylephrine peak in the calcium (Ca+2) free medium. They
used rabbits (1–1.5 kg; n = 20) and male Sprague–Dawley
rats (200–250 g; n = 50) of either sex. The ndings suggested
that crude extract of Acorus calamus contains a combination
of constituents which shows blood pressure lowering effect
mediated by Ca+2 antagonism and nitric oxide pathways and
vasoconstrictor effects to counteract the excessive vasodilatation. This study gives a base for the medicinal use of the
Acorus calamus in hypertension.
3.2 Amla (Emblica ocinalis Gaertn.,
Euphorbiaceae)
Amla is from the Indian subcontinent; however, countries
like Pakistan, China, Malaysia, Southeast Asia, and
Uzbekistan also cultivated and used it as a source of nutrition and therapeutic implications [26]. The hydroalcoholic
extract of the herb Emblica ofcinalis (E. ofcinalis) has
9.4% polyphenols (notably 30% emblicanin A, 28% embli-
canin B, 13% punigluconin, and 15% pedunculagin), 0.58%
alkaloids, 0.11% avonoids, and 0.85% vitamin C [27].
Deoxycorticosterone acetate 1% NaCl high salt (DOCA/
HS-induced hypertension) induces an oxidative process
that leads to cardiac dysfunction, renal impairment, and
renovascular dysfunction; nevertheless, it may be advantageous due to its anti-oxidant effects. Hypertension induced
by (20 mg/kg, s.c.) DOCA-salt was used twice a week for 5
weeks with the replacement of drinking water and 1%
sodium chloride solution. Rats were cotreated for the same
period with E. ofcinalis at effective therapeutic doses of
75, 150, and 300 mg/kg/day. Nitric oxide production in the
blood increased along with decreased sodium (Na+) and
potassium (K+) levels, all related to E. ofcinalis antihypertensive effects. Furthermore, endothelial nitric oxide
synthase (eNOS), an alcoholic herb extract, signicantly
increased heart levels. As a sustained dose compared to
DOCA control rats, E. ofcinalis considerably reduced oxidative stress, raised blood pressure, heart rate, and cardiovascular and nephrotic hypertrophy through regulating
serum nitric oxide, electrolyte, an endogenous anti-oxidant,
and enforced eNOS level [26].
3.3 Arjuna (Terminalia arjuna Roxb.,
Combretaceae)
Meghwani etal. [28] investigated Terminalia arjuna for its
potential to prevent pulmonary hypertension (PH) in Wistar
rats instigated by monocrotaline (MCT). Rats (150–200 g)
were used in the study and arbitrarily separated into ve
groups; Sildenal (175 mg/kg/day 3 days after MCT for 25
days), once MCT 50 mg/kg given by s.c., and aqueous
extract of Arjuna (125,250 mg/kg/day through oral route)
were all received. Arjuna and Sildenal both prevented right
ventricle hypertrophy and RVSP caused by MCT.Although
Bcl2/Bax gene expression was substantially revealed to be
suppressed in the right ventricle during MCT-induced PH,
Nicotinamide Adenine Dinucleotide Oxidase expression
was considerably boosted in the lung. In conclusion, the
aqueous extract of Terminalia arjuna reduced PH due to its
anti-oxidant capacity and effects on the thickness of the pulmonary artery.
134
https://t.me/medicina_free
J. S. Bankar et al.
3.4 Ashwagandha (Withania somnifera.,
Solanaceae)
The given study was completed to determine the mechanism
of Withania somnifera (WS) in myocardial damage. In the
current exploration experiment, Wistar rats were divided into
three groups, i.e. sham (LAD was not ligated), control, and
WS-50 mg/kg. Each group received normal saline for 1
month. On the 31 days, rats from the control IR and WS-IR
groups had their left anterior descending (LAD) coronary
arteries obstructed for 45 min, followed by an hour of reperfusion. Cardiac necrosis was caused by post-ischemic reperfusion injury when the IR control group was compared to the
sham group, which showed increased lipid peroxidation and
decreased anti-oxidant capacity. The given study revealed
that the anti-oxidant and anti-apoptotic properties of WS
may support its heart-protective effect [29].
3.5 Betel Leaf (Piper betel., Piperaceae)
Arya etal. [30] investigated the cardioprotective potential of
Piper betel against isoproterenol (ISP)-induced myocardial
infarction in rats. On days 28, 29, and 30, ISP (85 mg/kg,
s.c.) was administered at intervals of 24 h, and functional and
biochemical parameters were measured. In addition to
increasing lipid peroxidation, ISP signicantly decreased the
myocardial anti-oxidants superoxide dismutase, catalase,
peroxidases, reduced glutathione, and myocyte damage
marker enzymes creatine phosphokinase-MB isoenzyme and
lactate dehydrogenase; the results revealed that the hydroalcoholic extract of P. betel (150 and 300 mg/kg) showed the
signicant cardioprotective effect against ISP-induced myocardial infarction. This study suggested the cardioprotective
potential of P. betel.
3.6 Bera or Mamyanu (Ziziphus oxyphylla.,
Rhamnaceae)
Ziziphus oxyphylla (Z. oxyphylla) has long been used to
treat hypertension. It contains more derivatives of quercetin, kaempferol, catechin, and cyclopeptide alkaloids. The
hydroalcoholic extract of Z. oxyphylla (HAEZO) was prepared, and their anti-hypertensive effect was studied.
NG-nitro-L-arginine methyl ester (L-NAME) was used to
induce hypertension in rats. The study of the antihypertensive effects of HAEZO (200 and 400 mg/kg) and
Kaempferol (100 mg/kg) was administered through intraperitoneal injections of L-NAME (185 umol/kg) in hypertensive rats. HPLC and ESI-MS/MS determined kaempferol,
quercetin, catechin, ceanothic acid, zizybernalic acid, and
oxyphylline F. After chronic HAEZO and kaempferol
administration, systolic, diastolic, and mean blood pressure
in L-NAME- induced hypertensive rats were effectively (p
< 0.001) decreased. Serum nitric oxide and cGMP levels
were signicantly (p < 0.001) elevated. Oxidative stressrelated inammatory markers (MDA, CAT, SOD, GSH)
were also enhanced by HAEZO and kaempferol administration. In hypertensive animals, the increased IL-6 and
TNF- α concentrations were signicantly reduced by
HAEZO treatment. The anti-hypertensive effects of
HAEZO also caused endothelial nitric oxide synthase to be
upregulated and angiotensin- converting enzyme to be
downregulated [31].
3.7 Candlenut Tree (Aleurites moluccana.,
Euphorbiaceae)
The importance of an alcoholic extract from Aleurites moluccana leaves to lower lipid prole status was investigated
using a high-fat diet supplemented with rats and Triton
W-1339. These dried leaves (600 g) were cut into small
pieces before being macerated at room temperature for 10
days to produce the methanol extract. The administration of
leaf extract showed a signicant reduction in body weight in
Triton-induced hypercholesterolemic rats and serum cholesterol without any drop in the regular diet. The results provided the potential of this natural product to lower cholesterol
by its capacity to bring down intestinal lipid utilization and
inhibit the synthesis of hepatic cholesterol [32].
3.8 Cinnamon (Cinnamomum verum.,
Lauraceae)
In one study carried out in 30 male Wistar rats (8-weeksolds) weighing 250–300 g, long-term aerobic training and
administration of cinnamon extract affecedt cardiac function, biochemical alterations, and lipid prole following
exhaustive exercise. The study included a progressive
increase in training speed and duration incorporated into an
8-week endurance training regimen. A catheter with a balloon tip was inserted into the left ventricles to measure the
myocardial hemodynamics. Blood samples were taken to
examine lipid proles, biochemical indicators, and the lipidperoxidation marker malondialdehyde (MDA).
Simultaneously, physical exercise and cinnamon administration positively affected cardiac hemodynamics. Regular
training and cinnamon supplementation reect increased
high-density lipoprotein (HDL) and HDL/LDL ratio and
decreased serum total cholesterol level, low- density lipoprotein (LDL). Reduced serum MDA levels, improved blood
lipid prole, where cinnamon and regular exercise also positively affected cardiac function [33].
Herbal Medicines fortheManagement ofDiseases intheHeart, Circulation, andBlood
https://t.me/medicina_free
135
3.9 Drumstick (Moringa oleifera Lam.,
Moringaceae)
Indians utilize the Moringa oleifera Lam. leaves as a hypocholesterolemic medication in people with obesity. Hence,
the medical evidence for their usage in hypercholesterolemia
was explored. In the experiment, 15 male Wistar rats were
used, and it was determined that a high-fat diet increased the
serum, liver, and kidney cholesterol by (115-103.2 mg/100
mL of serum), (9.4-8.8 mg/g wet weight), and (1.09-0.97
mg/g wet weight), i.e. 14.35%, 6.4%, and 11%, respectively.
However, when M. oleifera aqueous crude leaf extract was
administered, these increased levels were found to be
reduced. The serum cholesterol effect was signicant, and
there was no signicant effect on serum total protein. The
aqueous crude extract showed an increase in serum albumin
by 15.22% (46–53 g/L). The statistical signicance of this
value was also determined. The study concluded that M. ole-
ifera leaves exhibited marked hypocholesterolemic action
and have a sound pharmacological background in India [34].
3.10 Garlic (Allium sativum., Liliaceae)
Garlic (Allium sativum) is widely available and utilized
worldwide as a spice, food ingredient, and home remedy.
Garlic has been a component of folk medicine for thousands
of years and has been used to treat many illnesses. Many
studies have been published about preventing atherosclerosis, coronary thrombosis, and stroke. The garlic effect has
been evaluated for its ability to prevent thromboxane production and platelet aggregation. The study determined the
impact of garlic aqueous bulb extract on thromboxane and
prostacyclin generation in whole rabbit blood and aorta
invitro and exvivo. During blood clotting, a dose-dependent
reduction of thromboxane synthesis was observed. Any concentration of garlic extract employed in the experiment did
not affect prostacyclin production. The maximum concentration of garlic utilized in invitro tests resulted in a small but
negligible decrease in prostacyclin vascular synthesis. The
aorta’s ability to produce thromboxane was inhibited at all
the measured garlic concentrations. After receiving an intraperitoneal injection of garlic (1 mL/kg) for a week, it was
observed that the ex vivo thromboxane and prostacyclin
enzymatic synthesis of these tissues showed a similar pattern. Garlic treatment signicantly boosted the aortic production of prostacyclin as compared to control rabbits. The
study ndings suggested that garlic administration may
selectively reduce platelet aggregation and production of
thromboxane while protecting vascular prostacyclin synthesis [35].
3.11 Gentiana (Gentiana oribunda.,
Gentianaceae)
The investigation was done on Gentiana oribunda (G.
oribunda) for its possible effect against hypertension
and as a vasodilator. Hydroalcoholic extract of the whole
plant was used in the study, and as a model, male Sprague–
Dawley rats (240–260 g) were used. G. oribunda contains avonoids, saponins, sterols, tannins, and terpenes,
which cause falls in BP in anaesthetized rats in a dosedependent (3.0–100 mg/kg) manner, and its vasodilator
effect was endothelial- independent. Compared to verapamil, the drug showed a reduction in contraction induced
by high K+ (80 mM) and phenylephrine (1M) at concentrations between 1.0 and 10 mg/mL.Also, it shifted the
Ca+2 dose–response curves to the right. These ndings
suggested that G. oribunda gives blood pressure-lowering action mediated by Ca+2 antagonism and is helpful in
hypertension [36].
3.12 Ginko (Gingko biloba., Ginkgoaceae)
In the present research attempt, Tiana etal. [37] discovered
the action of Ginkgo biloba (G. biloba) on endoplasmic
reticulum stress (ERS) and autophagy. Using network pharmacology, the targets, metabolic routes of the G. biloba
leaves and phytochemical constituents responsible for attenuating atherosclerosis (AS) are forecast. In this study, male
−/−
ApoE
(50 mg/kg/day) was administered to ApoE
toneally along with a high-fatty diet which caused diabetes.
As indicated by network pharmacology, the active chemical
constituents of G. biloba extract (GBE) were targeted at the
NF-B and mTOR signalling pathways to lower AS. G. biloba
also decreased blood glucose levels and inammatory
cytokines.
the effects of G. biloba treatment on blood pressure, vascular
tone, and calcium mobilization. Wistar Kyoto (WKY) and
spontaneously hypertensive rats (SHR) were given either a
control food or a diet containing 0.05–0.5% ginkgo for 30
days. While ginkgo powder was administered to WKY, it
showed no effect but a signicant drop in systolic blood pressure in SHR. As per network pharmacology prediction,
chemical compounds of GBE targeted the mammalian target
of rapamycin (mTOR) and NF-κB signalling pathways to
lowered AS.GBE decreased plaque/lumen area and plaque
lipid deposition area/intimal area while inhibiting CD68,
MMP2, and MMP9 expression.
mice aged 6–7 weeks animal used. Streptozotocin
−/−
mice intraperi-
To assess clinical availability, Kubota etal. [38] examined
Соседние файлы в папке Библиотека им академика М.И. Перельмана